Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 7.

Journal Article

Bruggen, M-C., Valencak, J., Stranzenbach, R., Li, N., Stadler, R., Jonak, C., Bauer, W., Porkert, S., Blaschke, A., Meiss, F., Nicolay, J. P., Wehkamp, U., Schlaak, M., Nguyen, V. A., Romani, N., Cozzio, A., Gayathri, N., Dimitriou, F., French, L. E., Dummer, R. and Guenova, E. (2020). Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. J. Eur. Acad. Dermatol. Venereol., 34 (7). S. 1489 - 1496. HOBOKEN: WILEY. ISSN 1468-3083

Schlaak, M., Kurschat, P., Shimabukuro-Vornhagen, A., Scheid, C., Chemnitz, J., Stadler, R., von Bergwelt-Baildon, M. and Theurich, S. (2011). Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation. Transpl. Immunol., 25 (2-3). S. 163 - 167. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 0966-3274

Stranzenbach, R., Dippel, E., Schlaak, M. and Stadler, R. (2018). Alternate dosing regimens of brentuximab vedotin for CD30+cutaneous T-cell lymphoma: reply from the authors. Br. J. Dermatol., 178 (1). S. 303 - 304. HOBOKEN: WILEY. ISSN 1365-2133

Stranzenbach, R., Dippel, E., Schlaak, M. and Stadler, R. (2017). Brentuximab vedotin in CD30(+) cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature. Br. J. Dermatol., 177 (6). S. 1503 - 1510. HOBOKEN: WILEY. ISSN 1365-2133

Theurich, S., Mueller, P., Martin, K., Savic, S., Terszowski, G., Lardinois, D., Schlaak, M., Stadler, R., Kvasnicka, H. -M., Spagnoli, G., Dirnhofer, S., Speiser, D. E., von Bergwelt-Baildon, M. and Zippelius, A. (2014). Beyond cytotoxicity: Implications for immune mediated mechanisms of action of brentuximab vedotin treatment in CD30(+) lymphomas. Oncol. Res. Treat., 37. S. 31 - 32. BASEL: KARGER. ISSN 2296-5262

Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Rabenhorst, A., Hartmann, K., Shimabukuro-Vornhagen, A., Schloesser, H., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2014). Tumor infiltrating B-cells in primary cutaneous T-cell lymphoma correlate with disease progression and might represent a novel target for immunotherapy. Exp. Dermatol., 23 (3). S. E25 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625

Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Shimabukuro-Vornhagen, A., Schloesser, H., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2014). Tumor infiltrating B-cells in primary cutaneous T-cell lymphoma correlate with disease progression and might represent a novel target for immunotherapy. Oncol. Res. Treat., 37. S. 31 - 32. BASEL: KARGER. ISSN 2296-5262

This list was generated on Fri Mar 29 12:44:20 2024 CET.